These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 23003125

  • 1. Prevalence and clinical significance of low-avidity HPA-1a antibodies in women exposed to HPA-1a during pregnancy.
    Peterson JA, Kanack A, Nayak D, Bougie DW, McFarland JG, Curtis BR, Aster RH.
    Transfusion; 2013 Jun; 53(6):1309-18. PubMed ID: 23003125
    [Abstract] [Full Text] [Related]

  • 2. Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia.
    Bakchoul T, Kubiak S, Krautwurst A, Roderfeld M, Siebert HC, Bein G, Sachs UJ, Santoso S.
    Transfusion; 2011 Nov; 51(11):2455-61. PubMed ID: 21564107
    [Abstract] [Full Text] [Related]

  • 3. Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia.
    Bakchoul T, Boylan B, Sachs UJ, Bein G, Ruan C, Santoso S, Newman PJ.
    Transfusion; 2009 Feb; 49(2):265-70. PubMed ID: 19000229
    [Abstract] [Full Text] [Related]

  • 4. Human platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model.
    Jackson DJ, Eastlake JL, Kumpel BM.
    Clin Exp Immunol; 2014 Apr; 176(1):23-36. PubMed ID: 24261689
    [Abstract] [Full Text] [Related]

  • 5. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
    Kjeldsen-Kragh J, Bengtsson J.
    Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neonatal alloimmune thrombocytopenia caused by anti-HPA antibodies in pregnant Chinese women: a study protocol for a multicentre, prospective cohort trial.
    Chen L, Liu Z, Liu T, Ma X, Rao M, Wang Y, Sun B, Yin W, Zhang J, Yan B, Li X, Wang Q, Zhang L, Wen J, Liu F, Wang P, Wei Y, Huang Y, Wu J, Guo Y, Kang Y, Song X, Liu X, Zhang G, Xie T, Chen Y, Zeng X, Li Z.
    BMC Pregnancy Childbirth; 2017 Aug 31; 17(1):281. PubMed ID: 28859622
    [Abstract] [Full Text] [Related]

  • 9. Foetal and neonatal alloimmune thrombocytopenia - The role of the HLA-DRB3*01:01 allele for HPA-1a-immunisation and foetal/neonatal outcome.
    Kjeldsen-Kragh J, Ahlen MT.
    Transfus Apher Sci; 2020 Feb 31; 59(1):102707. PubMed ID: 31919011
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low-avidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology.
    Socher I, Andrei-Selmer C, Bein G, Kroll H, Santoso S.
    Transfusion; 2009 May 31; 49(5):943-52. PubMed ID: 19175553
    [Abstract] [Full Text] [Related]

  • 12. The prevalence of HPA-1a alloimmunization and the potential risk of FNAIT depend on both the DRB3*01:01 allele and associated DR-DQ haplotypes.
    Ahlen MT, Heide G, Husebekk A, Skogen B, Kjeldsen-Kragh J, Stuge TB.
    Scand J Immunol; 2020 Jul 31; 92(1):e12890. PubMed ID: 32299122
    [Abstract] [Full Text] [Related]

  • 13. T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a-specific, HLA-DRB3*0101-restricted CD4+ T cells.
    Ahlen MT, Husebekk A, Killie MK, Skogen B, Stuge TB.
    Blood; 2009 Apr 16; 113(16):3838-44. PubMed ID: 19136661
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.
    Bakchoul T, Greinacher A, Sachs UJ, Krautwurst A, Renz H, Harb H, Bein G, Newman PJ, Santoso S.
    Blood; 2013 Jul 18; 122(3):321-7. PubMed ID: 23645838
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypes.
    Ahlen MT, Husebekk A, Killie MK, Kjeldsen-Kragh J, Olsson ML, Skogen B.
    Clin Dev Immunol; 2012 Jul 18; 2012():156867. PubMed ID: 22110529
    [Abstract] [Full Text] [Related]

  • 18. Maternal HLA genotyping is not useful for predicting severity of fetal and neonatal alloimmune thrombocytopenia.
    Sainio S, Javela K, Tuimala J, Haimila K.
    Br J Haematol; 2017 Jan 18; 176(1):111-117. PubMed ID: 27748520
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
    Kjaer M, Bertrand G, Bakchoul T, Massey E, Baker JM, Lieberman L, Tanael S, Greinacher A, Murphy MF, Arnold DM, Baidya S, Bussel J, Hume H, Kaplan C, Oepkes D, Ryan G, Savoia H, Shehata N, Kjeldsen-Kragh J, International Collaboration for Transfusion Medicine Guidelines.
    Vox Sang; 2019 Jan 18; 114(1):79-94. PubMed ID: 30565711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.